seed
Stage
2
Investors
About
Coherence Neuro develops SOMA, a therapeutic neurotechnology platform consisting of a wireless brain implant, an over-ear wearable, and an app that monitors and delivers personalized neurostimulation to manage cancer by disrupting tumor bioelectric signaling.
Explore Coherence Neuro's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.